Earnings Call · Q4 FY2025·2026-02-24

Q4 25EPS +79.17%·Rev n/aQ3 25EPS -18.75%·Rev n/aQ2 25EPS +29.41%·Rev n/aQ1 25EPS -7.14%·Rev n/a⚠ consensus missing

AbCellera Biologics Inc. ABCL

Tryn Stimart — Chief Legal and Compliance Officer

Carl L. Hansen — President and CEO

Andrew Booth — Chief Financial Officer

+6.3%1d on move date+5.5% vs SPY3d+18.5%5d+26.1%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ABCL calls or request research access.

More ABCL calls Browse calls Request research access